Charlotte Delrue

Charlotte Delrue

Auto-generated profile, based on publicly available information

Charlotte Delrue

Ghent University Hospital

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2023 in Critical Reviews in Clinical Laboratory Sciences
Verified
Journal Article
Closed access
Joris DelangheJoris Delanghe
Joris Delanghe
CDCharlotte Delrue
Charlotte Delrue
RSReinhart Speeckaert
Reinhart Speeckaert
MSMarijn M. Speeckaert
Marijn M. Speeckaert
Haptoglobin (Hp) is a polymorphic protein that was initially described as a hemoglobin (Hb)-binding protein. The major functions of Hp are to scavenge Hb, prevent iron loss, and prevent heme-based oxidation. Hp regulates angiogenesis, nitric oxide homeostasis, immune responses, and prostaglandin synthesis. Genetic polymorphisms in the Hp gene give rise to different phenotypes, including Hp 1-1, Hp 2-1, and Hp 2-2. Extensive research has been conducted to investigate the association between Hp polymorphisms and several medical conditions including cardiovascular disease, inflammatory bowel disease, cancer, transplantation, and hemoglobinopathies. Generally, the Hp 2-2 phenotype is associated with increased disease risk and poor outcomes. Over the years, the Hp 2 allele has spread under genetic pressures. Individuals with the Hp 2-2 phenotype generally exhibit lower levels of CD163 expression in macrophages. The decreased expression of CD163 may be associated with the poor antioxidant capacity in the serum of subjects carrying the Hp 2-2 phenotype. However, the Hp 1-1 phenotype may confer protection in some cases. The Hp1 allele has strong antioxidant, anti-inflammatory, and immunomodulatory properties. It is important to note that the benefits of the Hp1 allele may vary depending on genetic and environmental factors as well as the specific disease or condition under consideration. Therefore, the Hp1 allele may not necessarily confer advantages in all situations, and its effects may be context-dependent. This review highlights the current understanding of the role of Hp polymorphisms in cardiovascular disease, inflammatory bowel disease, cancer, transplantation, hemoglobinopathies, and polyuria.

19 November 2026 in Kidney International
Verified
Journal Article
Closed access
CDCharlotte Delrue
Charlotte Delrue
MSMarijn M. Speeckaert
Marijn M. Speeckaert

17 August 2026 in Acta Clinica Belgica
Verified
Journal Article
Closed access
CDCharlotte Delrue
Charlotte Delrue
Marijn M. SpeeckaertMarijn M. Speeckaert
Marijn M. Speeckaert


18 February 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CDCharlotte Delrue
Charlotte Delrue
ZGZen Van Gaever
Zen Van Gaever
SRShana De Ruyck
Shana De Ruyck
MOMatthijs Oyaert
Matthijs Oyaert
JDJo Van Dorpe
Jo Van Dorpe
RSReinhart Speeckaert
Reinhart Speeckaert

4 October 2026 in Acta Clinica Belgica
Verified
Journal Article
Closed access
CDCharlotte Delrue
Charlotte Delrue
Marijn M. SpeeckaertMarijn M. Speeckaert
Marijn M. Speeckaert
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have introduced a fundamental change in how we treat chronic kidney disease (CKD) and heart failure. Initially developed to reduce blood sugar, the...